Evidence map›Paper›PMID 37171612›Full record

ArticleMikrochimica acta2023

Pt Nanodot Inlaid Mesoporous NaBiOF Nanoblackberry for Remarkable Signal Amplification Toward Biomarker Detection.

Ruizhuo Ouyang, Weilun Zhang, Jinyao Liu, Yuhao Li, Jing Zhang, Lan Jiang, Yuefeng Zhao, Hui Wang, Chenyu Dai, Abel Ibrahim Balbín Tamayo and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Ruizhuo Ouyang *Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China. ouyangrz@usst.edu.cn.ORCID http://orcid.org/0000-0003-0562-7569
Weilun Zhang *Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Jinyao Liu *Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Yuhao Li *Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Jing Zhang *Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Lan JiangInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Yuefeng ZhaoInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Hui WangInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Chenyu DaiInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Abel Ibrahim Balbín TamayoUSST-UH International Joint Laboatory for Tumor Diagnosis and Energy Treatment, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Baolin LiuUSST-UH International Joint Laboatory for Tumor Diagnosis and Energy Treatment, University of Shanghai for Science and Technology, Shanghai, 200093, China. blliuk@usst.edu.cn.
Yuqing MiaoInstitute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai, 200093, China. yqmiao@usst.edu.cn.
University of Shanghai for Science and Technology · CN

Funding

Clinical research project of Shanghai Municipal Health Commission 201940078Natural Science Foundation of Shanghai 19ZR1434800Scientific research program of Shanghai Science and Technology Commission 21140903200
6 · The paper itself

Abstract

A new ultrasensitive sandwich-type electrochemical immunosensor has been successfully constructed to quantitatively detect carcinoembryonic antigen (CEA) using blackberry-like mesoporous bismuth-based nanospheres NaBiOF (NBOF NSs) inlaid with Pt nanodots (NDs) (BiPt NSs) as the antibody capture and signal-amplifying probe. The growth of Pt NDs inside the holes of NBOF NSs formed the nanozyme inlay outside NBOF NSs, greatly increasing the specific surface area and exposure of the catalytic active sites by minimizing the particle size of the Pt to nanodot scale. Such a blackberry-shaped heterojunction structure of BiPt NSs was well-suited to antibody capture and improved the catalytic performance of BiPt NSs in reducing H

Indexed as

Biosensing TechniquesMetal NanoparticlesNanotubes, CarbonAntibodiesAntibodies, ImmobilizedCarcinoembryonic AntigenElectrochemical TechniquesGoldHumansHydrogen PeroxideImmunoassayReproducibility of ResultsAntibodiesAntibodies, ImmobilizedCarcinoembryonic AntigenGoldHydrogen PeroxideNanotubes, CarbonBiPt NSsCEA detectionChronoamperometryHuman blood analysisImmunosensorMWCNTs

Identifiers

PMID37171612
OpenAlexW4376224363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.